Abstract
DJ-1 was initially identified as an oncogene product involved in human tumorigenesis in cooperation with Ras. Increased DJ-1 expression is associated with tumorigenesis in many cancers, whereas the loss of DJ-1 function is linked to an autosomal recessive form of Parkinson's disease (PD). It has been reported that DJ-1 protects cells from TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. However, the mechanism by which DJ-1 is involved is still largely unknown. Here we show that DJ-1 inhibits TRAIL-induced apoptosis by blocking Fas-associated protein death domain (FADD)-mediated pro-caspase-8 activation. Wild-type DJ-1, but not the PD-associated mutant L166P, binds to FADD to inhibit the formation of the death-inducing signaling complex (DISC). DJ-1 competes with pro-caspase-8 to bind to FADD at the death effector domain, thereby repressing the recruitment and activation of pro-caspase-8 to the active form of caspase-8. Thus, our study suggests that DJ-1 protects against TRAIL-induced apoptosis through the regulation of DISC formation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agata N, Ahmad R, Kawano T, Raina D, Kharbanda S, Kufe D . (2008). MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8. Cancer Res 68: 6136–6144.
Andres-Mateos E, Perier C, Zhang L, Blanchard-Fillion B, Greco TM, Thomas B et al. (2007). DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci USA 104: 14807–14812.
Ashkenazi A, Dixit VM . (1998). Death receptors: signaling and modulation. Science 281: 1305–1308.
Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P et al. (2000). TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2: 241–243.
Boldin MP, Goncharov TM, Goltsev YV, Wallach D . (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803–815.
Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E et al. (2003). Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256–259.
Bretaud S, Allen C, Ingham PW, Bandmann O . (2007). p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J Neurochem 100: 1626–1635.
Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S et al. (2004). The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 101: 9103–9108.
Chang DW, Xing Z, Capacio VL, Peter ME, Yang X . (2003). Interdimer processing mechanism of procaspase-8 activation. EMBO J 22: 4132–4142.
Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP . (2006). DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 103: 15091–15096.
Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalo P, Oriente F et al. (1999). PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18: 4409–4415.
Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M et al. (2008). Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol 39: 87–95.
Earnshaw WC, Martins LM, Kaufmann SH . (1999). Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383–424.
Fan J, Ren H, Jia N, Fei E, Zhou T, Jiang P et al. (2008a). DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 283: 4022–4030.
Fan J, Ren HG, Fei EK, Jia NL, Ying Z, Jiang P et al. (2008b). Sumoylation is critical for DJ-1 to repress p53 transcriptional activity. FEBS Lett 582: 1151–1156.
Foti R, Zucchelli S, Biagioli M, Roncaglia P, Vilotti S, Calligaris R et al. (2010). Parkinson disease-associated DJ-1 is required for the expression of the glial cell line-derived neurotrophic factor receptor RET in human neuroblastoma cells. J Biol Chem 285: 18565–18574.
Friedlander RM . (2003). Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348: 1365–1375.
Giaime E, Sunyach C, Druon C, Scarzello S, Robert G, Grosso S et al. (2010). Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ 17: 158–169.
Hanahan D, Weinberg RA . (2000). The hallmarks of cancer. Cell 100: 57–70.
Hod Y . (2004). Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem 92: 1221–1233.
Johnstone RW, Frew AJ, Smyth MJ . (2008). The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8: 782–798.
Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM . (2005). Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA 102: 9691–9696.
Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC et al. (2005). DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7: 263–273.
Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S et al. (2001). Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 7: 3328–3335.
Li H, Zhu H, Xu CJ, Yuan J . (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491–501.
Macedo MG, Anar B, Bronner IF, Cannella M, Squitieri F, Bonifati V et al. (2003). The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. Hum Mol Genet 12: 2807–2816.
MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y, Ting JP . (2003). Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 63: 6928–6934.
Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH et al. (1997). FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16: 2794–2804.
Miller DW, Ahmad R, Hague S, Baptista MJ, Canet-Aviles R, McLendon C et al. (2003). L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J Biol Chem 278: 36588–36595.
Mo JS, Kim MY, Ann EJ, Hong JA, Park HS . (2008). DJ-1 modulates UV-induced oxidative stress signaling through the suppression of MEKK1 and cell death. Cell Death Differ 15: 1030–1041.
Moore DJ, Zhang L, Dawson TM, Dawson VL . (2003). A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J Neurochem 87: 1558–1567.
Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM et al. (1997). DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509–513.
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M et al. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43.
Nieminen AI, Partanen JI, Hau A, Klefstrom J . (2007). c-Myc primed mitochondria determine cellular sensitivity to TRAIL-induced apoptosis. EMBO J 26: 1055–1067.
Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SM, Ariga H . (2003). DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res 1: 247–261.
Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM . (1998). Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533–33539.
Olzmann JA, Brown K, Wilkinson KD, Rees HD, Huai Q, Ke H et al. (2004). Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem 279: 8506–8515.
Pardo M, Garcia A, Thomas B, Pineiro A, Akoulitchev A, Dwek RA et al. (2006). The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer 119: 1014–1022.
Ren H, Fu K, Mu C, Li B, Wang D, Wang G . (2010). DJ-1, a cancer and Parkinson's disease associated protein, regulates autophagy through JNK pathway in cancer cells. Cancer Lett 297: 101–108.
Riedl SJ, Shi Y . (2004). Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897–907.
Scaffidi C, Kirchhoff S, Krammer PH, Peter ME . (1999). Apoptosis signaling in lymphocytes. Curr Opin Immunol 11: 277–285.
Shinbo Y, Niki T, Taira T, Ooe H, Takahashi-Niki K, Maita C et al. (2006). Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ 13: 96–108.
Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B et al. (2009). The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int J Cancer 125: 783–790.
Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X et al. (1998). Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273: 27084–27090.
Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SM, Ariga H . (2001). DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J Biol Chem 276: 37556–37563.
Thornberry NA, Lazebnik Y . (1998). Caspases: enemies within. Science 281: 1312–1316.
Tillman JE, Yuan J, Gu G, Fazli L, Ghosh R, Flynt AS et al. (2007). DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Res 67: 4630–4637.
Vasseur S, Afzal S, Tardivel-Lacombe J, Park DS, Iovanna JL, Mak TW . (2009). DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci USA 106: 1111–1116.
Wang S, El-Deiry WS . (2003). TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22: 8628–8633.
Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673–682.
Xu J, Zhong N, Wang H, Elias JE, Kim CY, Woldman I et al. (2005). The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet 14: 1231–1241.
Zhang HY, Wang HQ, Liu HM, Guan Y, Du ZX . (2008). Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells. Endocr Relat Cancer 15: 535–544.
Acknowledgements
We grateful to Dr Juha Klefstrom (University of Helsinki, Finland) and Dr Xiaolu Yang (University of Pennsylvania) for the kind gifts of pC4M-Fv2E-caspase-8 and the pC4M-Fv2E-caspase-8 C-A mutant and Mian Wu (University of Science and Technology of China, China) for the pGBKT7-FADD plasmid. The ARGENT Regulated Homodimerization Kit was kindly provided by ARIAD Pharmaceuticals (www.ariad.com/regulationkits). This work was supported in part by the National Natural Sciences Foundation of China (No. 30970921) and the National High-tech Research and Development program of China 973-projects (2011CB5004102).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Fu, K., Ren, H., Wang, Y. et al. DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD. Oncogene 31, 1311–1322 (2012). https://doi.org/10.1038/onc.2011.315
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.315
Keywords
This article is cited by
-
Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer
Nature Biomedical Engineering (2020)
-
DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells
Oncogene (2018)
-
Familial Parkinson’s Disease-Associated L166P Mutant DJ-1 is Cleaved by Mitochondrial Serine Protease Omi/HtrA2
Neuroscience Bulletin (2017)
-
A proteomic analysis of mushroom polysaccharide-treated HepG2 cells
Scientific Reports (2016)
-
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Acta Neuropathologica (2014)